Reproductive carrier testing receives full public funding in Australia
1 November 2023
From today, reproductive carrier testing for Spinal Muscular Atrophy, Cystic Fibrosis and Fragile X syndrome, which previously cost more than $385, will be covered by Medicare.
This has been a long time in the planning, and we are super excited that all Australians, not just to those that can afford the test, will now be able to make informed choices about their reproductive plans prior to deciding to start a family or in the early stages of pregnancy.
Please see the media release attached here.